About
FAQ
Reports
Contact Us
Works
Groups
People
Publications
Publishers
In Press
Advanced
1 Result
People
Kharas
Vu
Groups
Alumni (GSK)
(1)
Center for Hematologic Malignancies
(1)
GSK Faculty
(1)
Gerstner Sloan Kettering Graduate School of Biomedical Sciences
(1)
Hematologic Malignancies Research
(1)
Molecular Pharmacology and Chemistry Program Faculty
(1)
Sloan Kettering Institute Faculty
(1)
Sloan Kettering Institute Postdocs
(1)
Tow Center for Developmental Oncology (TCDO)
(1)
"Hematologic Malignancies Research"
"Center for Hematologic Malignancies"
"Ly Vu"
"Sloan Kettering Institute Faculty"
"Cancer Cell"
Formats
Journal Article (1)
Groups
Alumni (GSK) (1)
Center for Hematologic Malignancies (1)
GSK Faculty (1)
Gerstner Sloan Kettering Graduate School of Biomedical Sciences (1)
Hematologic Malignancies Research (1)
Molecular Pharmacology and Chemistry Program Faculty (1)
Alumni (GSK) (1)
Center for Hematologic Malignancies (1)
GSK Faculty (1)
Gerstner Sloan Kettering Graduate School of Biomedical Sciences (1)
Hematologic Malignancies Research (1)
Molecular Pharmacology and Chemistry Program Faculty (1)
Sloan Kettering Institute Faculty (1)
Sloan Kettering Institute Postdocs (1)
Tow Center for Developmental Oncology (TCDO) (1)
More Groups
Fewer Groups
People
Ly Vu (1)
Michael Kharas (1)
Years
2018 (1)
Publications
Cancer Cell (1)
Publishers
Cell Press (1)
Results (1)
Export to EndNote / Excel
Show:
10
20
50
100
250
500
1000
2000
Sort By:
Author
Title
Year
Relevance
Created
Order:
Ascending
Descending
Style:
Nature
NLM
NIH-PMCID
Citation style sort is year ascending, and then by author or title. Author ascending is default.
Targeting the residual leukemia cells after chemotherapy
Journal Article
Vu, L. P.
;
Kharas, M. G.
Cancer Cell
(2018)
Fulltext@MSK
|
Save